Psoriasis and diffuse systemic sclerosis: a report of three patients

Beverley Harrison; Ariane L. Herrick; Christopher Em Griffiths

doi:10.1093/rheumatology/39.2.213

Related publications

Article2021

Systemic Sclerosis and Pulmonary Hypertension

Claudia Baratto, Sergio Caravita, Giovanni Battista Perego, Luigi P. Badano, Jean‐Luc Vachiéry, Gianfranco Parati

Article2019

Persistence and effectiveness of systemic therapies for psoriasis

K.J. Mason, S. Williams, Zenas Z N Yiu, Kathleen McElhone, Darren M. Ashcroft, C. Elise Kleyn, Zarif K. Jabbar‐Lopez, Caroline Owen, Nick J. Reynolds, Catherine Smith, Nina Wilson, Richard B. Warren, Christopher Em Griffiths

Article2017

Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies

Christopher Em Griffiths, Maurizio Fava, Andrew H. Miller, James Russell, Susan Ball, Wen Xu, Nayan Acharya, Mark Hyman Rapaport

Article2004

Side effects of systemic treatment for psoriasis

CO Mendonca, Christopher Em Griffiths

Article2018

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy

Zenas Z N Yiu, Christina Sorbe, Mark Lunt, Stephan Jeff Rustenbach, L Kühl, Matthias Augustin, K.J. Mason, Darren M. Ashcroft, Christopher Em Griffiths, Richard B. Warren, Anthony D. Ormerod, Juliet N. Barker, Ian Evans, Kathleen McElhone, Catherine Smith, Nick J. Reynolds, Ruth Murphy, Marilyn Benham, A. David Burden, Sagair Hussain, Brian Kirby, Linda Lawson,